Fundraising FoxQualigen Therapeutics
Carlsbad,, US · Founded 2008 · Delaware corporation · 1 known investors
Find your way into Qualigen Therapeutics
Sign up to see every warm intro you have to Qualigen Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Qualigen Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KR
Kevin Richardson IIInterim CEO/CFO & Board Member2024–2025
JW
John W. BeckExecutive
IE
Ira E. RitterNamed on SEC filing
WM
William M. MerinoNamed on SEC filing
MD
Michael D. StepNamed on SEC filing
MW
Matthew W. FoehrNamed on SEC filing
PV
Paul V. MaierNamed on SEC filing
AJ
Andrew J. RitterNamed on SEC filing
Board
BL
Braeden LichtiBoard director
ND
Noah DoyleBoard director
GB
Graydon BenslerBoard director
RL
Robert LimBoard director
Investors · 1
Sequoia CapitalreportedMenlo Park · $100K – $50M
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.8M disclosed across 5 rounds · 2012–2025
▶$4.5MraisedAug 2025 · 14 investors · BiotechnologyRule 506(b)
▶$4.5MraisedAug 2025 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert B. LimDirector
- Braeden LichtiDirector
- Kevin Richardson IIDirector
- Campbell BecherExecutive Officer, Director
- Cody PriceDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- Placement agents
- Univest Securities LLC
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedNov 2024 · 33 investors · BiotechnologyRule 506(b)
▶$5.1MraisedNov 2024 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Braeden LichtiDirector
- Graydon BenslerDirector
- Robert LimDirector
- Kevin Richardson IIExecutive Officer
- Campbell BecherDirector
- Cody PriceDirector
- Offering amount
- $5.1M
- Amount sold
- $5.1M
- Sales commissions
- $408K
- Placement agents
- Univest Securities LLC
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedNov 2018 · 11 investors · BiotechnologyRule 506(b)
▶$6MraisedNov 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ira E. RitterExecutive Officer, Director
- John W. BeckExecutive Officer
- Noah DoyleDirector
- William M. MerinoDirector
- Michael D. StepDirector
- Matthew W. FoehrDirector
- Paul V. MaierDirector
- Andrew J. RitterExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $1K
- Sales commissions
- $367.5K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedDec 2014 · 4 investors · PharmaceuticalsRule 506(b)
▶$3.7MraisedDec 2014 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. RitterExecutive Officer, Director
- Michael D. StepExecutive Officer, Director
- Noah DoyleDirector
- Thomas AdamekDirector
- Ira E. RitterExecutive Officer, Director
- Offering amount
- $5.7M
- Amount sold
- $3.7M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$526.4KraisedFeb 2012 · 1 investors · Other Health CareRule 506(b)
▶$526.4KraisedFeb 2012 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- THOMAS ADAMEKDirector
- NOAH DOYLEDirector
- ANDREW RITTERExecutive Officer
- LEE WILLIAMSPromoter
- IRA RITTERExecutive Officer, Director
- STEVEN MARKOWITZDirector
- Offering amount
- $3.5M
- Amount sold
- $526.4K
- Minimum investment
- $25K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Qualigen Therapeutics's investors?
- Qualigen Therapeutics's investors include Sequoia Capital.
- How much funding has Qualigen Therapeutics raised?
- Qualigen Therapeutics has disclosed $19.8M raised across 5 rounds.
- Where is Qualigen Therapeutics headquartered?
- Qualigen Therapeutics is headquartered in Carlsbad,, US.